Key Highlights
- Oceania Healthcare Limited (ASX:OCA) reports underlying EBITDA of NZ$49.0 million for the six months to 30 September 2026, up 18%.
- Annuity EBITDA rose 83% to NZ$34.5 million, and Cash Flow from Existing Operations turned positive, improving by NZ$7.0 million.
- Net profit from continuing operations was a loss of NZ$4.4 million, while total comprehensive income was NZ$5.3 million.
- Gearing was reduced to 29.6%, with NZ$226 million of funding headroom, and no Dividend was declared.
Oceania Healthcare Limited (ASX:OCA, NZX:OCA) has reported its interim result for the six months to 30 September 2026, with underlying EBITDA up 18% to NZ$49.0 million. The results were released on 19 November 2026. Chief Executive Suzanne Dvorak said the company had delivered positive cash flow from its operations in the half, which it had identified as the key priority in its FY26 result.
Earnings and Revenue
Revenue from continuing operations was NZ$127.3 million, down 3% on the prior period. Underlying EBITDA was NZ$49.0 million, up 18%, and Annuity EBITDA was NZ$34.5 million, up 83%. Care annuity EBITDA per bed rose 48% to NZ$24.4 thousand.
Net loss from continuing operations was NZ$4.4 million, a 190% change on the prior period. Total comprehensive income was NZ$5.3 million, down 87%, reflecting lower Revaluation gains.
Cash Flow and Balance Sheet
Cash Flow from Existing Operations was positive, improving by NZ$7.0 million from the first half of FY26. The company attributes this to cash generation and cost savings. Gearing was reduced to 29.6%, and funding headroom stands at NZ$226 million. Net tangible assets were NZ$1.63 per share, up from NZ$1.57.
The company is reporting these non-IFRS measures alongside its unaudited interim financial statements, and refers readers to its results presentation for reconciliations.
Operations and Resales
The company recorded a record first-half result for resales, with 200 resales, up 11%, at higher margins. Management says the improved performance reflects continued execution of the FY27 strategy.
Ms Dvorak said the focus now is on sustaining that performance through the second half.
Looking Ahead
The second half of FY27 will show whether positive Operating Cash Flow can be sustained and whether resales and per-bed annuity Earnings continue to grow. The company has not declared a dividend for the period.






Please wait processing your request...